Increasing Collaborations and Partnership for CDx Test Development to Drive the Global Companion Diagnostics Demand Close to USD 6.51 Billion by 2022
The key factors driving the growth of Companion Diagnostics market include the increasing lung cancer cases, growing number of genetic testing, rising need for personalized medicines, and regulatory guidelines that support the global market.
View full press release